We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06237920
Title Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab (TURANDORELA)
Acronym TURANDORELA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Netherlands Cancer Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Facility Status City State Zip Country Details
Radboud University Medical Center RECRUITING Nijmegen Gelderland 6525GA Netherlands Details
NKI-AVL RECRUITING Amsterdam Noord-Holland 1066CX Netherlands Details
Amsterdam UMC (AUMC) RECRUITING Amsterdam Noord-Holland 1081HV Netherlands Details
Leiden University Medical Center (LUMC) RECRUITING Leiden Zuid-Holland 2333ZA Netherlands Details
Erasmus Medical Center RECRUITING Rotterdam Zuid_Holland 3015GD Netherlands Details
University Medical Center Utrecht RECRUITING Utrecht 3584CX Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field